Lixte Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIXT and other ETFs, options, and stocks.About LIXT
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets.
CEOGeordan G. Pursglove
CEOGeordan G. Pursglove
Employees2
Employees2
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2005
Founded2005
Employees2
Employees2
LIXT Key Statistics
Market cap25.02M
Market cap25.02M
Price-Earnings ratio-3.44
Price-Earnings ratio-3.44
Dividend yield—
Dividend yield—
Average volume74.82K
Average volume74.82K
High today$4.19
High today$4.19
Low today$3.95
Low today$3.95
Open price$4.14
Open price$4.14
Volume45.19K
Volume45.19K
52 Week high$6.26
52 Week high$6.26
52 Week low$0.64
52 Week low$0.64
Stock Snapshot
Lixte Biotechnology(LIXT) stock is priced at $3.99, giving the company a market capitalization of 25.02M. It carries a P/E multiple of -3.44.
On 2025-12-15, Lixte Biotechnology(LIXT) stock traded between a low of $3.95 and a high of $4.19. Shares are currently priced at $3.99, which is +1.0% above the low and -4.8% below the high.
The Lixte Biotechnology(LIXT)'s current trading volume is 45.19K, compared to an average daily volume of 74.82K.
During the past year, Lixte Biotechnology(LIXT) stock moved between $0.64 at its lowest and $6.26 at its peak.
During the past year, Lixte Biotechnology(LIXT) stock moved between $0.64 at its lowest and $6.26 at its peak.
People also own
Based on the portfolios of people who own LIXT. This list is generated using Robinhood data, and it’s not a recommendation.